Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.705
-0.295 (-5.90%)
Sep 8, 2026, 2:23 PM EDT - Market open

TriSalus Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
45.0845.1529.4318.5112.48.4
Revenue Growth
25.25%53.41%58.99%49.31%47.58%54.60%
Gross Profit
38.6738.1925.3315.9110.147.21
Operating Income
-30.51-26.95-36.17-50.18-36.44-24.03
Net Income
-57.25-69.69-33.23-63.6-50.02-28.85
Earnings Per Share
-1.15-1.84-1.31-6.77-161.55-3.25
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
46.2920.448.5311.789.4130.3
Total Debt
34.4334.4423.631.61.96-
Net Cash (Debt)
11.86-14-15.110.187.4530.3
Net Cash Growth
---36.65%-75.41%-
Net Cash Per Share
0.24-0.37-0.601.0824.073.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-22.8-18.01-40.84-50.58-32.31-22.7
Capital Expenditures
-0.48-0.92-0.35-0.59-0.66-1.1
Free Cash Flow
-23.28-18.93-41.19-51.17-32.97-23.79
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
85.79%84.57%86.06%85.93%81.79%85.80%
Operating Margin
-67.68%-59.68%-122.88%-271.06%-293.91%-286.06%
Pretax Margin
-62.56%-86.86%-102.07%-320.64%-380.53%-343.32%
Profit Margin
-127.00%-154.35%-112.92%-343.59%-403.42%-343.35%
FCF Margin
-51.65%-41.93%-139.95%-276.41%-265.91%-283.23%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.837.725.1912.0125.2836.75